The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
1
|
J | Antiinfectives for systemic use | |
2
|
J01 | Antibacterials for systemic use | |
3
|
J01A | Tetracyclines | |
4
|
J01AA | Tetracyclines | |
5
|
J01AA13 |
| Active Ingredient |
|---|
|
Eravacycline is an antibacterial drug. Its mechanism of action involves the disruption of bacterial protein synthesis by binding to the 30S ribosomal subunit thus preventing the incorporation of amino acid residues into elongating peptide chains. |
| Document | Type | Information Source | |
|---|---|---|---|
| XERAVA Powder for solution for infusion | MPI, EU: SmPC | European Medicines Agency (EU) | |
| XERAVA Powder for solution for injection | MPI, US: SPL/PLR | FDA, National Drug Code (US) |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.